[go: up one dir, main page]

WO2003041687A3 - Procede de production de solutions stables de substances phenoliques et les solutions en resultant - Google Patents

Procede de production de solutions stables de substances phenoliques et les solutions en resultant Download PDF

Info

Publication number
WO2003041687A3
WO2003041687A3 PCT/FR2002/003922 FR0203922W WO03041687A3 WO 2003041687 A3 WO2003041687 A3 WO 2003041687A3 FR 0203922 W FR0203922 W FR 0203922W WO 03041687 A3 WO03041687 A3 WO 03041687A3
Authority
WO
WIPO (PCT)
Prior art keywords
solutions
phenolic substances
deoxygenation
gas
invention concerns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2002/003922
Other languages
English (en)
Other versions
WO2003041687A2 (fr
Inventor
Bernard Dinnequin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Aguettant SAS
Original Assignee
Laboratoire Aguettant SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Aguettant SAS filed Critical Laboratoire Aguettant SAS
Priority to US10/495,841 priority Critical patent/US7199269B2/en
Priority to EP02803055A priority patent/EP1443902A2/fr
Publication of WO2003041687A2 publication Critical patent/WO2003041687A2/fr
Publication of WO2003041687A3 publication Critical patent/WO2003041687A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte au domaine de la chimie thérapeutique et plus particulièrement au domaine de la pharmacotechnie. Elle a plus particulièrement pour objet un nouveau procédé de production de solutions à base de substances phénoliques stabilisés n'incluant pas d'agent anti-oxydant dans lequel on procède à la désoxygénation des solutions par un gaz inerte d'une part, et à la désoxygénation des volumes morts des cuves, des canalisations de fabrication ainsi qu'à un inertage des ampoules ou flacons contenant le soluté par un gaz inerte rare dense tel que l'argon, en opérant à basse température et à pH ajusté au-dessus de 3,0 et en dessous de 5,0 pour obtenir des solutions stables de substances phénoliques contenant moins de ou au plus 0,02 ppm d'oxygène dans la solution, que l'on filtre par double filtration stérilisante. Utilisation en thérapeutique humaine ou animale.
PCT/FR2002/003922 2001-11-15 2002-11-15 Procede de production de solutions stables de substances phenoliques et les solutions en resultant Ceased WO2003041687A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/495,841 US7199269B2 (en) 2001-11-15 2002-11-15 Method for producing stable solutions of phenolic substances and resulting solutions
EP02803055A EP1443902A2 (fr) 2001-11-15 2002-11-15 Procede de production de solutions stables de substances phenoliques et les solutions en resultant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01/14796 2001-11-15
FR0114796A FR2832063B1 (fr) 2001-11-15 2001-11-15 Procede de production de solutions stables de substances phenoliques et les solutions en resultant

Publications (2)

Publication Number Publication Date
WO2003041687A2 WO2003041687A2 (fr) 2003-05-22
WO2003041687A3 true WO2003041687A3 (fr) 2004-03-04

Family

ID=8869440

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/003922 Ceased WO2003041687A2 (fr) 2001-11-15 2002-11-15 Procede de production de solutions stables de substances phenoliques et les solutions en resultant

Country Status (4)

Country Link
US (1) US7199269B2 (fr)
EP (1) EP1443902A2 (fr)
FR (1) FR2832063B1 (fr)
WO (1) WO2003041687A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
US20120245230A1 (en) 2009-12-10 2012-09-27 Tecnimede-Sociedade Tecnico- Medicinal, S.A. Method and composition for preparing stable liquid formulations of paracetamol
US20110207824A1 (en) * 2010-02-25 2011-08-25 Moly Pharma Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution
PT2680832T (pt) 2011-03-04 2019-10-28 Gruenenthal Gmbh Formulação farmacêutica aquosa de tapentadol para administração oral
CN103371969A (zh) * 2012-04-17 2013-10-30 上海禾丰制药有限公司 重酒石酸间羟胺注射液及其制剂工艺
UY35988A (es) * 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
PT3142651T (pt) * 2014-05-13 2019-03-21 Centre Hospitalier Regional Et Univ De Lille Solução farmacêutica compreendendo dopamina para uso no tratamento da doença de parkinson
PL2990031T3 (pl) 2014-08-28 2020-05-18 Sun Pharmaceutical Industries Ltd Pozajelitowa postać norepinefryny
CN104523582A (zh) * 2014-12-16 2015-04-22 成都新恒创药业有限公司 一种稳定的硫酸特步他林注射液及制备工艺
HRP20190231T1 (hr) 2015-03-27 2019-04-05 Grünenthal GmbH Stabilna formulacija za parenteralnu primjenu tapentadola
EP3120837A1 (fr) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Solution de bortezomib prêts à l'emploi
JP7160799B2 (ja) 2016-09-23 2022-10-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口投与用安定製剤
WO2018140894A1 (fr) 2017-01-30 2018-08-02 Nevakar, Inc Compositions de norépinéphrine et procédés associés
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
WO2019150381A1 (fr) * 2018-02-01 2019-08-08 Joshi Mahendra R Composition pharmaceutique stable et procédé de production d'une injection de chlorhydrate d'isoprotérénol
FR3095122B1 (fr) * 2019-04-18 2021-04-09 Crossject Solution pharmaceutique d’adrénaline pour dispositif d’injection
EP4114336A1 (fr) 2020-03-06 2023-01-11 Baxter International Inc. Système de récipient scellé conditionné de stockage stable de formulation pharmaceutique sensible à l'oxygène
IL302239B2 (en) * 2020-10-21 2024-07-01 Sintetica S A Stable, injectable noradrenaline solutions free of antioxidants
WO2022084775A1 (fr) 2020-10-21 2022-04-28 Sintetica S.A. Poches de perfusion prêtes à l'emploi, à faible nombre de particules subvisibles
CN114601791B (zh) * 2020-12-08 2023-09-19 成都倍特药业股份有限公司 一种盐酸米托蒽醌液体制剂及其制备方法
CN112826793A (zh) * 2021-01-25 2021-05-25 石家庄四药有限公司 一种硫酸特布他林注射液及其制备方法
JP2025530388A (ja) 2022-09-14 2025-09-11 インブレイン・ファーマ ドパミンを含む医薬用注入溶液
CN116983259A (zh) * 2023-09-27 2023-11-03 成都瑞尔医药科技有限公司 一种依托泊苷注射液的制备方法
CN119745847A (zh) * 2025-01-10 2025-04-04 上海上药第一生化药业有限公司 一种盐酸多巴酚丁胺药组合物及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619A1 (fr) * 2000-06-06 2001-12-07 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619A1 (fr) * 2000-06-06 2001-12-07 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention

Also Published As

Publication number Publication date
WO2003041687A2 (fr) 2003-05-22
US7199269B2 (en) 2007-04-03
US20050070613A1 (en) 2005-03-31
FR2832063A1 (fr) 2003-05-16
FR2832063B1 (fr) 2004-08-27
EP1443902A2 (fr) 2004-08-11

Similar Documents

Publication Publication Date Title
WO2003041687A3 (fr) Procede de production de solutions stables de substances phenoliques et les solutions en resultant
SE7704774L (sv) Behandling av organiskt avfall
AU3069284A (en) Water sterilisation apparatus
BR9605888A (pt) Processos para preparação de produto(s) liquido(s) para criação e preparação de solução medicinal para criação de solução para diálise
MXPA04004800A (es) Metodo para preparar una composicion que contiene al menos un producto de deshidratacion interna de un azucar hidrogenada.
DE69724618T2 (de) Mesembrin und verwandte verbindungen enthaltende pharmazeutische zusammensetzungen
BRPI0410685B8 (pt) processos de purificação do 1,3-propanodiol e composição
AU2003223990A1 (en) Filtration devices
DK1465641T3 (da) Lægemidler indeholdende deuterium til behandling af sukkersyge
WO2003037863A3 (fr) Indoles substitues, procede pour leur preparation et leur utilisation pour lutter contre la douleur
JPS5359254A (en) Method of purifying waste liquid produced from photographic treatment using sulfur bacteria and method of recoveryof silver from waste liquid of photographic treatment
DK0576335T3 (da) Fremgangsmåde til rensning af en vandig opløsning af alkalimetalchlorid for at fjerne iod
WO2005044733A3 (fr) Enrichissement des eaux a traiter ameliorant la formation et la croissance des hydrates pour desalinisation
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
IL177286A0 (en) Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
TW200509903A (en) A method of purifying moxidectin through crystallization
EP1050525A4 (fr) Substances capables de provoquer l'apoptose
ATE212553T1 (de) Verwendung von isoosmotische salzlösungen zur herstellung von cerumenolytischer pharmazeutischer präparate
DE60034110D1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
JP2005021875A (ja) 水の酸化還元電位を維持する方法
DE50308954D1 (de) Kombinierte biotechnologisch-chemische Methode zur Behandlung von flüssigen Abfällen aus der Produktion von Tafeloliven
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
JPS56128711A (en) Glucose-electrolyte preparation for high-calorie transfusion
JPS5722688A (en) Concentration of liquid containing nutrient component
BR0307879A (pt) Método para purificar um composto de nióbio e/ou um composto de tântalo altamente puro

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): BR CA CN DZ EE IL IN JP KR LT LV MA MK MX NO PL RO RU SI SK TN TR US VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002803055

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10495841

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002803055

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP